COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D PXPX FLVFLV PVP-IPI BUBU BHBH BLBL CICI HC QHC Q NZNZ COCO More..
Ivermectin study #31 of 90
11/11 Early treatment study
Krolewiecki et al., SSRN (Preprint)
Antiviral Effect of High-Dose Ivermectin in Adults with COVID-19: A Pilot Randomised, Controlled, Open Label, Multicentre Trial
Source   PDF   Share   Tweet
Viral load RCT finding a concentration dependent antiviral activity of oral high dose ivermectin at a dosing regimen that is well tolerated.
There was no significant difference in viral load reduction between groups overall, but a significant difference in reduction was found in patients with higher median plasma ivermectin levels (72% vs. 42%, p=0.004).
Decay rate was significantly greater in patients with higher median plasma ivermectin levels (0.64 vs. 0.13, p = 0.011).
Mean ivermectin plasma concentration levels showed a positive correlation with viral decay rate (r = 0.46, p = 0.02).
30 ivermectin patients and 15 control patients.
NCT004381884

Krolewiecki et al., 11/11/2020, preprint, 24 authors.
Details of all 90 studies    Meta analysis
Please send us corrections, updates, or comments. Vaccines and treatments are both extremely valuable and complementary; multiple approaches are required to cover all people and all existing and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. Treatment protocols for physicians are available from the FLCCC.
  or use drag and drop to submit images   
Submit